Harbour Capital Advisors LLC Sells 1,984 Shares of UnitedHealth Group Incorporated $UNH

Harbour Capital Advisors LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 16.9% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 9,781 shares of the healthcare conglomerate’s stock after selling 1,984 shares during the quarter. Harbour Capital Advisors LLC’s holdings in UnitedHealth Group were worth $3,557,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also made changes to their positions in the company. Caitlin John LLC raised its position in UnitedHealth Group by 14.8% in the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after acquiring an additional 111 shares during the period. Murphy Pohlad Asset Management LLC raised its holdings in UnitedHealth Group by 21.8% in the 2nd quarter. Murphy Pohlad Asset Management LLC now owns 4,425 shares of the healthcare conglomerate’s stock worth $1,380,000 after purchasing an additional 791 shares during the period. Berkshire Hathaway Inc bought a new stake in UnitedHealth Group during the second quarter valued at about $1,572,193,000. Triumph Capital Management bought a new position in shares of UnitedHealth Group in the second quarter worth about $1,324,000. Finally, Wealth Effects LLC grew its stake in shares of UnitedHealth Group by 14.4% during the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after acquiring an additional 591 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

UNH has been the topic of several analyst reports. Sanford C. Bernstein lifted their price target on shares of UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a report on Thursday, October 30th. TD Cowen upped their target price on shares of UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a report on Thursday, October 30th. JPMorgan Chase & Co. boosted their price objective on UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. Wells Fargo & Company lifted their target price on UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Finally, Royal Bank Of Canada upped their price target on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Seventeen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Hold” and a consensus price target of $385.54.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $328.41 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.82. The company has a market cap of $297.49 billion, a price-to-earnings ratio of 17.14, a PEG ratio of 2.16 and a beta of 0.43. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36. The stock’s 50 day simple moving average is $337.35 and its two-hundred day simple moving average is $317.91.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. During the same quarter in the previous year, the business posted $7.15 earnings per share. UnitedHealth Group’s quarterly revenue was up 12.2% on a year-over-year basis. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend was Monday, December 8th. UnitedHealth Group’s payout ratio is presently 46.14%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.